Working… Menu

Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04348513
Recruitment Status : Terminated (Due to specific inclusion criteria no more subjects could be enrolled.)
First Posted : April 16, 2020
Last Update Posted : September 23, 2021
Attikon Hospital
Information provided by (Responsible Party):
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.